Regulatory & Legal

A decorated 42-year Army veteran joins M1 Support Services to spearhead a radical, tech-driven transformation of how the Army trains helicopter pilots.

A North Carolina startup claims a massive efficiency leap in Direct Air Capture, putting the sub-$100/ton 'holy grail' of carbon removal within reach.

A startup using trained dogs and AI to sniff out cancer from breath samples was just named a "Fierce 15" company. Can this technology change screening?

With 8x sales growth and 90% prediction accuracy, AI pioneer QuantHealth is proving that simulating clinical trials can slash pharma's $50B failure rate.

The firm is integrating MSCI's advanced analytics platform, signaling a major shift towards hyper-personalized, data-driven advice for its clients.

Barfresh secures major financing to own its factory, aiming for massive growth. But as it navigates a complex deal, will the financial gamble pay off?

A novel stent designed specifically for the brain's veins shows immediate success in its first human tests, offering new hope for a debilitating condition.

A landmark European approval for Elfabrio allows stable Fabry disease patients to switch to monthly infusions, promising greater freedom and lower healthcare strain.

After a dramatic 2025 pivot from citrus, Alico's CEO is meeting investors to sell a new vision for its vast Florida land holdings and future growth.

As electroCore preps its 2025 financial report, all eyes are on its product growth, the new Quell device, and its path to profitability in the booming bioelectronic market.

With a new chairman at the helm, NATSO's 2026 board is set to navigate the complex challenges of EV charging, new regulations, and evolving customer demands.

A multi-year IP deal resolves all litigation, granting AMD access to key chip tech and validating Adeia's portfolio, reshaping the semiconductor landscape.

Medicus Pharma's microneedle patch for basal cell carcinoma clears nearly three-quarters of lesions, offering a potential non-surgical alternative to the scalpel.

With new data on CUE-401, a novel therapy inspired by Nobel-winning science, Cue Biopharma makes a high-stakes play to redefine autoimmune treatment.

A new documentary narrated by Jacqueline Bisset finally tells the story of the trailblazing women pilots of WWII who were forgotten by history.

A new class of software is helping cities turn sensor data into action, tackling the crisis of decaying public works with integrated, automated workflows.

A new AI signature from Caris Life Sciences aims to guide first-line therapy for a deadly cancer, facing hurdles of clinical validation and adoption.

As geopolitical conflicts roil global energy supply, traders flock to CME Group, smashing volume records and signaling extreme market volatility.

A new non-thermal ablation technology shows long-term success in shrinking thyroid nodules with high patient satisfaction, potentially disrupting surgical norms.

NGEx Minerals secures key environmental approval for its high-grade Lunahuasi project, signaling a new era of mining investment in Argentina's San Juan.